- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
As artificial intelligence continues to grow, it comes as little surprise that this innovative tech finds numerous applications in the healthcare sector. Here’s what investors need to know before they buy in.
Healthcare AI is a subcategory of artificial intelligence: a term broadly applied to machines programmed to think like humans. And as artificial intelligence becomes increasingly prevalent in our day-to-day lives, its applications continue to grow.
Healthcare AI focuses on the use of artificial intelligence to research, treat and prevent diseases. With artificial intelligence, we can assess complex data sets, streamline medical services and make groundbreaking discoveries. In turn, these discoveries fuel the advancement of new technologies and tools in the healthcare sector.
Stocks in the healthcare AI industry scale from big names in artificial intelligence, like Alphabet, to niche medical device manufacturers, like Globus Medical. See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.
There are numerous artificial intelligence ETFs, including the Invesco QQQ, iShares US Technology ETF and First Trust Dow Jones Internet Index. But if you’re looking for something specific to healthcare AI, take a look at the Robo Global Healthcare Technology & Innovation (HTEC).
The Robo Global Healthcare Technology & Innovation ETF was launched in 2019 by advisory and research firm Robo Global. It tracks over 80 US stocks in healthcare and artificial intelligence from the US and around the world.
To put it bluntly, there is high growth potential. The global AI healthcare market, worth $4.9 billion in 2020, is expected to grow to $45.2 billion by 2026 at a compound annual growth rate (CAGR) of 44.9%, according to Markets and Markets.
Growth potential aside, artificial intelligence in the healthcare industry has the potential to produce lifesaving technology. AI developments in this sector can change how we identify and treat disease. And to see this in action, we need to look no further than Google’s AI research firm, DeepMind.
DeepMind announced in later November 2020 that its AlphaFold system had finally solved a protein folding challenge — one that had baffled and eluded the scientific community for decades. The successful passing of this protein folding test meant that AlphaFold could decipher the structure of proteins from an amino acid sequence in just a few days, a resource-intensive task that used to take years.
DeepMind’s breakthrough showcases how powerful and prevalent AI technology has and will continue to be in the healthcare industry. And this emerging trend presents an invaluable opportunity for investors seeking growth stocks.
One of the most critical risks facing healthcare AI stocks is competition. Companies in sectors like this — sectors on the cusp of significant growth — may be vulnerable to the self-imposed volatility of a highly competitive playing field.
Investors interested in these stocks have a challenging choice to make: invest in riskier small-cap stocks that may not survive the competition, or shell out hundreds for a single share of an already-established tech giant, like Google’s parent company, Alphabet.
Another consideration is governmental regulation. Tech companies are far from immune to regulatory disputes, and as the way we interact with this type of technology continues to evolve, some companies may be forced to reconsider their approach — a potentially time and capital-intensive process.
To invest in healthcare AI stocks, you’ll need a brokerage account. Explore your platform options by features and fees to find the account that best meets your needs.
*Signup bonus information updated weekly.
Healthcare AI stocks have plenty of room to grow — and analysts are optimistic about this subsector’s potential. But governmental regulation coupled with a high degree of competition may threaten your investment in this category.
To invest in healthcare AI stocks, explore your brokerage account options with multiple platforms for the account best suited to your investment goals.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
We explore some of the best brokerage accounts for international stock trading. Here’s what you need to know.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.